← Back to news
Y

Yahoo Finance

Is Coca-Cola (KO) The Best Dividend Stock to Buy Amid AI Valuation Concerns?

Y

Stocks Waver as Wall Street Finally Gets Retail Sales, Producer Price Inflation Data

Y

NIO Net Loss Narrows on Strong Sales, Margin

Y

What Are Wall Street Analysts' Target Price for Deckers Outdoor Stock?

Y

Is Exxon Mobil Stock Underperforming the S&P 500?

Y

Reddit Loves Waste Management (WM) as a Top Non-AI Stock, Here’s Why

Y

Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here’s Why

Y

Do You Believe in the Upside Potential of Quaker Houghton (KWR)?

Y

FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation

Y

Is Berkshire Hathaway (BRK.B) The Top Stock to Save Your Portfolio Ahead of Potential AI Bubble Pop?

Y

TransDigm Group Stock: Is Wall Street Bullish or Bearish?

Y

H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion

Y

Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst

Y

Bitcoin Gets Kicked Out of the $2 Trillion Club. Here's Why This Top Bitcoin ETF Is a Buy Anyway.

Y

Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress

Y

William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty

Y

William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns

Y

Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges

Y

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns

Y

Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast

Y

Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance

Y

A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling

Y

What Makes Avient Corp (AVNT) a Lucrative Investment?

Y

Is UnitedHealth Group (UNH) The Best Non-Tech Stock to Buy? Reddit Says Yes

Y

I Think Gap (GAP) “Turns Out to be the Winner,” Says Jim Cramer

Y

Consumer Confidence Dives, Employment Falls, Supporting Fed Cut

Y

US retail sales miss expectations in September

Y

Is Visa (V) The Best Non-AI Stock to Buy Ahead of Potential Bubble Burst?

Y

Snap-on Stock: Analyst Estimates & Ratings

Y

Is Amgen Stock Underperforming the Nasdaq?

Y

Fund Takes Bold New Position: Is Transocean Stock a Good Buy?

Y

Soybeans Higher to Start Tuesday Trade

Y

Corn Ticking a Penny Higher on Tuesday Morning

Y

Ducommun (DCO) is Benefitting From Strong Demand

Y

A 17-Year-Old Dave Ramsey Caller Makes $1,700 At A Gym And Buys An $8,000 Honda Accord From A Friend. Now He's Stuck Paying $1,100 Per Month

Y

Best Buy ups sales outlook heading into holiday shopping ramp-up

Y

Stablecoin issuer Paxos to acquire wallet startup Fordefi for more than $100 million

Y

Homebuyers are using risky loans with the hope rates are going to eventually fall. Will the gamble be worth it?

Y

Here’s How the Acquisition Helps FTAI Infrastructure (FIP)

Y

Klarna Launches KlarnaUSD Stablecoin to Cut Global Payment Costs

Y

BofA Cautious on KBR (KBR) Amid Macro Headwinds, Impending Business Split

Y

Truist Lowers Shift4 Payments (FOUR) PT $74 on Uncertainty Over 2026 Organic Volume in Hospitality, Restaurant Sectors

Y

Dell, NVIDIA Announce Major Advancements to ‘AI Factory’ to Simplify, Boost Enterprise AI Performance

Y

Wells Fargo Initiates Carnival (CCL) Coverage with ‘Overweight’ Rating, $37 PT, Cites Attractive Cruise Sector Outlook

Y

Wells Fargo Raises Ovintiv (OVV) PT to $42, Cites Superior Montney Assets from NuVista Energy Acquisition

Y

Piper Sandler Lowers Permian Resources (PR) PT to $20 Despite Strong Q3 Production, Operational Improvement

Y

Wells Fargo Initiates Wyndham Hotels (WH) with ‘Equal Weight’, $82 PT

Y

RBC Capital Initiates Coverage of Axon Enterprise (AXON) with ‘Outperform’, $860 PT

Y

Jefferies Upgrades DoorDash (DASH) to ‘Buy’ with $260 PT, Cites Investment Flexibility, Long-Term AI Platform Potential

Y

Truist Cautious on Microchip Technology (MCHP) After Q3 Beat But Below-Consensus Q4 Guidance

Y